<DOC>
	<DOCNO>NCT01140399</DOCNO>
	<brief_summary>The purpose study determine whether patient acute decompensated congestive heart failure cardiorenal syndrome , i.e . state therapy direct improve symptom limit worsen renal function , fluid removal ultrafiltration superior different pharmacological approach acutely relieve congestion prevent deterioration renal function whether result longer admission-free survival 90 day enrolment</brief_summary>
	<brief_title>REWORD-HF REverse WOrsening Renal Function Decompensated Heart Failure</brief_title>
	<detailed_description>Acute decompensated congestive heart failure ( ADCHF ) , common single cause hospitalization 65 year , result 4-8 % in-hospital mortality 30-38 % incidence readmission within 3 month discharge . While fluid accumulation remain main factor cause hospitalization , impaired cardiac output ADHF cause renal arterial underfilling increase venous pressure , reduce glomerular filtration rate cause acute kidney injury . Aggressive therapy require alleviate volume overload hospital admission achievement dry weight capital prevent rehospitalisation . Currently diuretic consider standard care volume overload ADHF , yet patient , especially advanced HF become soon resistant standard dose loop diuretic , escalate dos association thiazide often require achieve effective diuresis , approach progressively worsen renal function , cause cardiorenal syndrome . When diuretic resistance develop symptom persists , mechanical fluid removal via ultrafiltration consider . Ultrafiltration alternative method sodium water removal , filter plasma water directly across semipermeable membrane response transmembrane pressure gradient , result ultrafiltrate isoosmotic compare plasma water , In view limit traditional therapy treatment congestion concomitant progressive renal dysfunction ADHF patient , compel need additional study individuate good method fluid removal volume-overloaded patient guide management decision reduce associate morbidity . The main objective present project evaluate whether patient acute decompensated congestive heart failure cardiorenal syndrome , i.e . state therapy direct improve CHF symptom limit worsen renal function , fluid removal ultrafiltration superior different pharmacological approach acutely relieve congestion prevent deterioration renal function whether result longer admission-free survival 90 day enrolment</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>Inclusion criterion On admission ( screen ) Informed consent Age 1880 year NYHA class III IV Signs pulmonary ( pulmonary rale , interstitial oedema pleural effusion chest Xray ) and/or systemic congestion ( pit ankle oedema enlarge liver ascites neck vein distension ≥ 7 cm ) weight gain ≥ 2 kg previous week Glomerular filtration rate ≥ 30 ml/min BNP increase &gt; 400 pg/ml ( diagnostic cutoff ADCHF ) , confirmatory diagnostic test ) 24 hour admission ( randomization ) Persistent sign pulmonary ( pulmonary rale , interstitial oedema pleural effusion chest Xray ) and/or systemic congestion ( ankle oedema , enlarge liver ascites , neck vein distension ≥ 7 cm ) Serum creatinine urine output criterion indicative modify RIFLE ( AKI : risk ) class least 1 ( increase x 1.5 serum creatinine decrease &gt; 25 % GFR urine output &lt; 0.5 ml/Kg/h 6 hour ) 2930 diuretic infusion Exclusion criterion Chronic kidney disease stage 45 ( GFR &lt; 30 ml/min ) Acute coronary syndrome Systolic blood pressure &lt; 90 mm Hg/need intravenous inotropes Hematocrit &gt; 45 % Unattainable venous access Contraindications anticoagulation heparin Systemic infection Heart transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>1 Acute Decompensated Heart Failure</keyword>
	<keyword>2 Cardiorenal Syndrome</keyword>
	<keyword>3 Ultrafiltration</keyword>
	<keyword>4 Dopamine</keyword>
</DOC>